Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.

Victor Gault, JC Parker, P Harriott, MH Mooney, Peter Flatt, Finbarr O'Harte

Research output: Contribution to journalArticle

LanguageEnglish
Pages36-36
JournalDiabetic medicine
Volume20 (S2
Publication statusPublished - 2003

Cite this

@article{5a87156bc9c341c0b7fdb648fffd6b21,
title = "Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.",
author = "Victor Gault and JC Parker and P Harriott and MH Mooney and Peter Flatt and Finbarr O'Harte",
year = "2003",
language = "English",
volume = "20 (S2",
pages = "36--36",
journal = "Diabetes Medicine",
issn = "0742-3071",

}

Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo. / Gault, Victor; Parker, JC; Harriott, P; Mooney, MH; Flatt, Peter; O'Harte, Finbarr.

In: Diabetic medicine, Vol. 20 (S2, 2003, p. 36-36.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.

AU - Gault, Victor

AU - Parker, JC

AU - Harriott, P

AU - Mooney, MH

AU - Flatt, Peter

AU - O'Harte, Finbarr

PY - 2003

Y1 - 2003

M3 - Article

VL - 20 (S2

SP - 36

EP - 36

JO - Diabetes Medicine

T2 - Diabetes Medicine

JF - Diabetes Medicine

SN - 0742-3071

ER -